I discuss Polarean Imaging #POLX Open Orphan #ORPH & Metro Bank #MTRO with Justin on the Vox Markets podcast. Interview is 30 minutes in
RNS Number: 0355 T Polarean Imaging PLC 12 November 2019 Polarean Imaging Plc. New System Delivery and Installation. Polarean Imaging plc, the medical-imaging technology company, with a proprietary drug-device combination product for the magnetic resonance imaging market, announces that further to the announcement of 15 February 2019, the Company has...
RNS Number: 7207 S Polarean Imaging PLC 08 November 2019 8 November 2019. Polarean Imaging plc, the medical-imaging technology company, with a proprietary drug-device combination product, announces that upon the recommendation of the Company's Remuneration Committee it has granted options over a total of 1,410,750 ordinary shares of £0.00037 in the...
RNS Number: 5570 S Polarean Imaging PLC 07 November 2019 7 November 2019. Completion of patient enrolment for Clinical Trials and PDMR Appointment. Polarean Imaging plc, the medical-imaging technology company, with a proprietary magnetic resonance imaging drug-device combination, announces that the enrolment for its Phase III non-inferiority clinical...
RNS Number: 6829 P Polarean Imaging PLC 11 October 2019 Polarean Imaging Plc. Polarean Imaging plc, the medical-imaging technology company, with a proprietary drug-device combination product, announces that it was notified on 10 October 2019 that Dr Jonathan Allis, a Non-Executive Director of the Company, purchased 1,540,000 Ordinary Shares of £0.00037 at...
RNS Number: 5523 P Polarean Imaging PLC 11 October 2019 Polarean Imaging Plc. Polarean notes statement from Amphion Innovations. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 2101 P Polarean Imaging PLC 09 October 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 5919 O Polarean Imaging PLC 03 October 2019 Polarean Imaging Plc. Polarean notes statement from Amphion Innovations. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 5457 N Polarean Imaging PLC 25 September 2019 Polarean Imaging Plc. Polarean notes statement from Amphion Innovations. Polarean Imaging plc, the medical-imaging technology company, with a proprietary drug-device combination product, notes the announcement made by its partner company, Amphion Innovations Plc that Amphion has agreed to amend...
Polarean Imaging Plc (POLX.L) Announced, in its interim results for the six months ended 30 June 2019, that revenues fell to $0.4 million from $1.0 million reported in the same period last year. The company’s loss before tax stood at $3.4 million compared to a loss of $2.8 million reported in the previous year. The basic loss per share stood at $0.034 compared to loss of $0.057 in the previous year. The company’s cash and cash equivalents stood at $1.3 million (2018: $1.4 million).
·Third trial site added at University of Cincinnati, in addition to Duke University and the University of Virginia, to improve enrolment rates for its Clinical Trials. ·Three new orders for Polarean's 9820 Xenon Polariser system from the University of British Columbia, The Hospital for Sick Children in Toronto and the University of Kansas..
RNS Number: 8812 L Polarean Imaging PLC 10 September 2019 Polarean Imaging Plc. Polarean notes statement from Amphion Innovations. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
Bid
-
-
-
Ask
  • High
    -
  • OPEN
    -
  • VOL
    -
  • MKT CAP
    -m
  • LOW
    -
  • CLOSE
    -
  • AVG VOL
    -
  • SHARES IN ISSUE
    114.44M

Featured Media

Company Profile

Polarean is manufacturer and service provider for noble gas polarizer devices and ancillary instruments with special focus on pulmonary imaging using hyperpolarized gas MRI. Current product offerings of Polarean include xenon-129 and helium-3 polarizers, polarization measurement stations and upgrade kits for existing polarizers.

Classification

Market Indices-

Locations

HQ
27-28 Eastcastle Street
London
W1W 8DH
Watchlist